9 results
Antiplatelet Conversion - Switching Between P2Y12 Inhibitors
Oral P2Y12 inhibitors vary in potency and pharmacokinetic and dynamic
Clopidogrel to Ticagrelor ... to Clopidogrel, Ticagrelor ... : Prasugrel to Ticagrelor ... , Ticagrelor to ... #antiplatelet #ticagrelor
Antiplatelet Conversion - Switching Between Oral P2Y12 Inhibitors
A, Switching between oral agents in the acute/early phase.
prasugrel (P) or ticagrelor ... last prasugrel or ticagrelor ... changing from ticagrelor ... the last dose of ticagrelor ... #antiplatelet #ticagrelor
Trends in Platelet Adenosine Diphosphate P2Y12 Receptor Inhibitor Use and Adherence Among Antiplatelet-Naive Patients After Percutaneous
Clopidogrel #Prasugrel #Ticagrelor
Antiplatelet Conversion - P2Y12 Inhibitor Switching
 • Clopidogrel (Plavix)
 • Prasugrel (Effient)
 • Ticagrelor (Brilinta)
Clopidogrel and
Prasugrel (Effient) • Ticagrelor ... Ticagrelor, a noncompetitive ... Reversible inhibitor: ticagrelor
Oral P2Y12 Inhibitor Pharmacology

 • Clopidogrel
 • Prasugrel
 • Ticagrelor

By Kyle Fischer, PharmD @Kfischer_10

#P2Y12 #Inhibitor #Pharmacology
Prasugrel • Ticagrelor
Very Quick Guide to Reversing Antithrombotic Therapy
Aspirin 
Clopidogrel 
Prasugrel 
Ticagrelor 
Abciximab 
Tirofiban 
Eptifibatide 
Unfractionated Heparin 
Low
Prasugrel Ticagrelor
Cangrelor - Pharmacology
Cangrelor (Kengreal) is a parenteral analogue of adenosine triphosphate
Cangrelor binds reversibly to the platelet
subtherapeutic levels • Ticagrelor ... Ticagrelor's half-life
Quick Guide to Reversing Antiplatelet and Antithrombotic Therapy
Aspirin, Clopidogrel, Prasugrel, Ticagrelor, Abciximab, Tirofiban, Eptifibatide, Unfractionated Heparin,
Clopidogrel, Prasugrel, Ticagrelor
Antiplatelet Medications - Summary Table

Aspirin - Inhibits cyclooxygenase, preventing formation of thromboxane A2
 • Acute coronary
clopidogrel, prasugrel, ticagrelor